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Abstract
Background: The impact of the COVID-19 pandemic has been measured in different metrics, mostly by counting
deaths and its impact on health services. Few studies have attempted to calculate years of life lost (YLL) to COVID-
19 and compare it with YLL due to other causes in different countries.
Methods: We calculated YLL to COVID-19 from week10 to week52 in 2020 for eight European countries by
methods defined by the WHO. We calculated excess YLL by subtracting the average YLL from 2017 to 2019 to the
YLL in 2020. Our analysis compared YLL to COVID-19 and the excess YLL of non-COVID-19 causes across countries
in Europe.
Results: Portugal registered 394,573 cases and 6619 deaths due to COVID-19, accounting for 25,395 YLL in just 10
months. COVID-19 was responsible for 6.7% of all deaths but accounted for only 4.2% of all YLL. We estimate that
Portugal experienced an excess of 35,510 YLL (+ 6.2%), of which 72% would have been due to COVID-19 and 28%
due to non-COVID-19 causes. Spain, Portugal, and the Netherlands experienced excess YLL to non-COVID-19 causes.
We also estimated that Portugal experienced an excess of 10,115 YLL due to cancer (3805), cardiovascular diseases
(786) and diseases of the respiratory system (525).
Conclusion: COVID-19 has had a major impact on mortality rates in Portugal, as well as in other European
countries. The relative impact of COVID-19 on the number of deaths has been greater than on the number of YLL,
because COVID-19 deaths occur mostly in advanced ages.
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Background
In 2020, the COVID-19 pandemic spread around the
world, causing serious effects on populations [1]. It is a
serious threat due to its high transmissibility and overall
lethality (1.7% in Portugal, 2.1% in Europe and 2.2%
worldwide as of 27 December 2020, not considering
under-ascertainment) [1, 2]. This is only comparable to
the Spanish flu in the year 1918, for which worldwide le-
thality is estimated to have been above 2.5% [3].
COVID-19 affects elderly people more severely [4]. In
Portugal, there have been relatively few deaths in pa-
tients under the age of 50, accounting for only 1.2% of
the total number of recorded deaths. On 27 December
2020, around 67.7% of COVID-19 deaths were recorded
among people aged 80+ years and 31.2% among those
aged 50 to 79 years of age [2].
The Centers for Disease Control and Prevention refers
to excess deaths (or excess mortality) as “the difference
between the observed numbers of deaths in specific time
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periods and expected numbers of deaths in the same time
periods” [5]. EUROMO counted excess mortality across
26 European countries in 2020, including that directly
attributed to COVID-19 [6]. However, not all excess
deaths were directly caused by COVID-19. Because
healthcare systems had to adapt to the overwhelming
demands of the pandemic, patients with other common
and serious diseases may have not received the level and
quality of care that they would have received under nor-
mal circumstances [7]. By late May 2020, England and
Wales, Italy, and Spain had already reported that 28.8,
32.5 and 61.8% of excess mortality, respectively, was not
due to COVID-19, often referring to it as non-COVID-
19 excess mortality or collateral mortality [8]. In
Portugal, the percentage of non-COVID-19 excess mor-
tality has fluctuated over time, from 51% between March
and mid-April, to 92% in July and finally to no excess
registered in December 2020 [8–10].
The number of deaths is an imperfect measure of
mortality, as it does not provide insight into the age dis-
tribution of deaths or how risk levels vary by age. It is
equally important to measure premature deaths, in
terms of the years expected to live in relation to the per-
son’s life expectancy (LE), and to account for the num-
ber of years living with a disability. These two
dimensions of the burden of disease can be expressed in
terms of potential years of life lost (YLL) due to prema-
ture death and to years lived with disability (YLD) [11].
The disability-adjusted life year (DALY) is a known
measure of the population’s health that results from
their sum [12]. This calculation takes into consideration
the age at which a certain death or health condition oc-
curred, which can be estimated for a certain disease or
group of diseases, using LE as the reference for the years
the person is expected to live. A higher YLL can be due
to larger numbers of death, deaths in younger ages, or
some combination of the two [13].
Cancer (CA), cardiovascular diseases (CVDs) and dis-
eases of the respiratory system (DRSs) are the most com-
mon causes of death in Portugal and tend to kill those
affected at younger ages [14]. In 2017, CVDs and CA were
the major causes of natural deaths worldwide for those
aged 15 to 49 years, accounting for 1.26 million deaths
and 1.06 million deaths, respectively [15]. The DRSs were
the third cause of death for people aged 50 to 69 years and
people aged 70+ years, accounting for 1 million deaths
and 3.96 million deaths registered, respectively [15, 16].
The estimation of the number of YLL due to COVID-
19 and due to other causes adds to the calculation of ex-
cess mortality. Several authors [17, 18] have developed
preliminary models for estimating YLL to COVID-19,
namely in Italy, where they estimated that the number
of YLL per patient due to COVID-19 was about 13 years
per male patient and 11 years per female patient.
This study aims to:
Calculate the burden of COVID-19, in terms of YLL,
due to premature deaths for Portugal and for other se-
lected European countries (France, Germany, Italy, the
Netherlands, Spain, Sweden, and the United Kingdom);
Estimate the excess YLL to non-COVID-19 diseases
(exc-YLL-non-Cvd) for all countries in the year 2020,
after week 10; and
Estimate the excess YLL in 2020 due to CA, CVDs, and
DRSs in the selected countries for the same period.
Methods
This is an observational, cross-sectional study. Our ana-
lysis rests on deaths registered by the Eurostat database
for all-cause mortality, from the Institut National
d’Études Démographiques [19] (INED) and from the
Northern Ireland Statistics and Research Agency [20]
(NISRA). The calculation method for each objective is
explained below:
YLL
To calculate YLL, we adapted the traditional method,
taking into consideration the scarcity of information on







YLL = years of life lost;
M = number of deaths registered in each age class;
LE = life expectancy at birth;
IRP = intermediate-range point of the age class; and.
i = Age classes with deaths.
Accessible data of the age at the time of deaths by
country is grouped in 5- or 10-year ranges, including
those due to COVID-19. All calculations for YLL were
performed for the counting deaths below the age of 80
years once the values for LE were narrowed to this age,
and this was an upper limit recommended by other
studies for these calculations [21]. Only data for
COVID-19 deaths in Scotland and Northern Ireland
were not performed in this way, due to the upper age
class being 74 to 85 years, making the inclusion of deaths
recorded in this range with values above the LE contrib-
uting to some reduction in the final estimate of the YLL
for that range.
Descriptive data of deaths by all causes and by
COVID-19 for each country can be accessed in
Additional file 1.
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Total YLL by COVID-19
To calculate YLL by COVID-19, Mi was replaced by the
number of deaths due to COVID-19 by age. Information
was retrieved from the INED [19] for all countries and
from the INED and NISRA [20] for the United Kingdom
(the INED for Scotland and England and Wales and the
NISRA for Northern Ireland). For these calculations, the
formula with the latest known LE value for each country
was used, without considering gender differentiation
(Additional file 1) [22].
To estimate the percentage of YLL by COVID-19 by
gender for each country, data about the LEs for males
and females were also retrieved for the latest value
known (Additional file 1) [22]. Due to a lack of data, this
calculation was not possible for Sweden.
Exc-YLL-non-CVD in 2020 by country
The exc-YLL-non-Cvd for each country for the period
covered by the study was calculated using the following
formula:
Excð Þ YLL non CvdYLL ¼ TotalYLL2020 -AverageYLL2017:2019 -COVIDYLL2020
For comparative purposes, we calculated the rates of
YLL by country population in order to achieve YLL per
10,000 habitants for each country [23].
We also calculated the ratio for each country between
the Exc-YLL-non-CVD/YLL COVID-19 for each
country.
To estimate the exc-YLL-non-Cvd by country, we
estimated the average number of YLL expected in
2020, based on the mortality registered in 2017–2019,
and compared it with that registered in 2020. We re-
trieved the mortality data by all-causes and by age be-
tween 2 March (week 10) and 27 December (week
52) for the years 2017, 2018, and 2019 from the
Eurostat database [24]. March was chosen because it
was when Europe surpassed 500 deaths registered by
COVID-19 [1]. When the data for 27 December were
not available, data were retrieved from the closest day
available. An exception was made for Italy, where
analyses were only performed until week 49, as the
data was available on the day of this study. The same
procedure was performed for the year 2020, to
achieve the total YLL in 2020, for the same weeks in
consideration. All estimations were performed with
the latest LE values known for both genders as men-
tioned above.
Then, we analysed the correlation between the YLL by
COVID-19 and the exc-YLL-non-Cvd found in the se-
lected countries through Pearson’s correlation, with a
statistical significance of 95%.
Exc-YLL-non-Cvd for disease groups in 2020 by country
Because mortality statistics by age and by specific causes
(i.e., the International Classification of Diseases [25]) for
some countries were only available until 2016 [26], we
estimated the YLL for each disease in 2020 based on the
percentage data from previous years (2012–2016). We
also included data from 28 European Union countries
for comparative purposes.
First, we calculated the percentage of YLL attributed
to each disease in each year using the data between 2012
and 2016 through the following formula:
Average % of YLL for a disease
¼
YLL for a disease 2012
All YLL 2012
þ …ð Þ þ YLL for a disease 2016
All YLL 2016
5
The LE used for the YLL calculation was the value of
each country in each year (Additional file 1) [22]. Then,
we calculated the percentage of YLL from premature
deaths for the selected group of diseases per year in rela-
tion to all YLL in that year. Thereby, we estimated the
average burden of each group of selected diseases (CA,
CVDs, and DRSs) over those 5 years.
Finally, we estimated the excess YLL for each group of
diseases in 2020 through the equation:
Excess YLL for a disease2020
¼ Exc YLL non CvdAverage%of YLL for a disease
We only presented the results when exc-YLL-non-Cvd
had a positive value and assumed that the proportion of
YLL by disease remained the same across the years.
Results
Burden of COVID-19 in terms of YLL
Between 2 March and 27 December 272,020, Portugal
registered 394,573 cases and 6619 deaths due to
COVID-19 [2]. Given the age at the time of death, these
deaths accounted for 25,395 YLL to COVID-19 in just
10 months (Table 1). During that period, the total YLL
due to premature deaths was 611,104 YLL. While
COVID-19 was responsible for 6.7% of all deaths, it
accounted for only 4.2% of YLL during this period.
Table 1 Number of Deaths and Years of Life Lost in Portugal
during the COVID-19 Pandemic (2 March-27 December 2020)
COVID-19 Non-COVID-19 Total
N° of deaths 6619 92,749 99,368
% 6.7 93.3 100.0
N° of YLL 25,395 585,710 611,104
% 4.2 95.8 100
YLL years of life lost
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COVID-19 affected older people disproportionately,
both in terms of the death rates and YLL per 10,000
population. Deaths from COVID-19 among people aged
60+ accounted for 70% of all YLL to COVID-19. In
France, those aged between 60 and 69 accounted for the
largest share of YLL, followed by Portugal. In the
Netherlands and Sweden, people aged 70+ accounted for
the largest share of YLL to COVID-19 (Fig. 1).
COVID-19 affected men disproportionately, account-
ing for most of the YLL in every country considered in
this study. Portugal was the country where there seemed
to be more of a gender balance (Additional file 1).
Excess YLL to COVID-19 and other causes during the
pandemic in 2020
Between 2 March 2 and 27 December 2020, Portugal
registered 38,308 deaths due to all causes among people
aged less than 80. During that period, the country regis-
tered 2140 deaths due to COVID-19 aged less than 80,
or 5.6% of all deaths. Based on the mortality rates be-
tween 2017 and 2019, we estimate that Portugal had an
excess of 35,510 YLL (+ 6.2%), of which 72% would have
been due to COVID-19 and 28% due to non-COVID-19
causes, respectively. Among the countries studied,
COVID-19 had a greater impact in Portugal in relation
to the number of excess YLL. All the European countries
considered, except for Germany, experienced overall ex-
cess mortality during the first year of the pandemic.
In Fig. 2, we can see that Portugal registered the high-
est rate of total YLL, 595 per 10,000 inhabitants in 2020,
followed by Germany (582), France (569), and the
United Kingdom (567). However, the United Kingdom
(62), Spain (55), and Italy (53) had the highest YLL per
10,000 inhabitants directly lost by COVID-19.
The total YLL was higher in 2020 than in 2017–2019
in every country considered in this study, except for
Germany, where it was nearly even (0.04%).
In addition to registering an excess YLL to COVID-19,
Portugal, Spain, and the Netherlands also registered an
excess YLL per 10,000 population to non-COVID-19
causes (exc-YLL-non-Cvd). In every country considered
here, COVID-19 accounted for most of the excess YLL
in 2020. However, Portugal reported the highest ratio
(40%) between excess YLL to non-COVID-19 causes
Fig. 1 Distribution of YLL by COVID-19 by age in selected countries
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and YLL to COVID-19 (see Additional file 1 for more
detail). This means that for every YLL to COVID-19,
there was 0.4 YLL to non-COVID-19 causes.
No correlation was found between YLL to COVID-19
and exc-YLL-non-Cvd among countries (r2 = 0.240, p =
0.568).
Estimation of excess YLL to CA, CVDs, and DRSs
Between 2012 and 2016, 235,133 people below the age
of 80 died in Portugal. CA, CVDs, and DRSs contributed
on average to 37.3, 22.7, and 7.3%, respectively, of all
deaths from all causes in individuals below the age of 80.
For that same period, CA, CVDs, and DRSs contrib-
uted to 37.6, 17.7, and 5.2%, respectively, of all YLL
among people aged less than 80 years (Additional file 1).
This relative distribution was similar in all other coun-
tries in the study, with a maximum variation between
countries of 9%.
CA accounts for a higher proportion of YLL in
Portugal than in the average of the 28 European Union
countries. Conversely, CVDs accounted for a smaller
proportion of YLL in Portugal compared to that in the
28 European Union countries.
Applying the relative distribution of the YLL per cause
observed in 2012–2016 to the YLL to non-COVID-19
deaths during this period of the pandemic, we estimated
that the number of YLL in excess due to CA, CVDs, and
DRSs from 2 March to 27 December 2020, in Portugal,
would have been 3805.3, 1786.3, and 524.5, respectively
(Table 2).
Fig. 2 YLL by country between week 10 and week 52 of 2020 due to COVID-19 and non-COVID-19 causes











Cancer (CA) Cardiovascular diseases (CVDs) Diseases of the respiratory system (DRSs)
France 229,009.1 -a -a -a -a
Germany 111,756.0 -a -a -a -a
Italy 318,760.0 -a -a -a -a
Netherlands 42,851.8 11,257.5 4998.9 1963.3 605.0
Portugal 25,394.5 10,115.0 3805.3 1786.3 524.5
Spain 259,059.0 85,926.47 36,608.3 15,942.6 5043.8
Sweden 32,356.0 -a -a -a -a
United Kingdom 422,118.0 -a -a -a -a
YLL years of life lost.
aNo excess YLL to non-COVID-19 disease
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Discussion
In this paper, we estimated that Italy, the United King-
dom, and Spain had the greatest amount of YLL directly
due to COVID-19 and that Spain, Portugal, and the
Netherlands had excess YLL due to non-COVID-19
causes.
Few studies have tried to estimate the YLL to COVID-
19 and to non-COVID-19 causes in 2020 [18, 21, 27].
This paper does not calculate the YLD and, conse-
quently, the DALYs [12] for COVID-19 because no firm
data exists (yet) for a deeper understanding of the long-
term effects of thisdisease, even though some COVID-19
survivors may report histological, imagiological, and epi-
demiological evidence that suggests they may produce
relevant burden of disease in futureyears [28–30]. The
most severe forms of acute disease seem to affect mainly
older people, many of whom already have significant co-
morbidities and disabilities, who end up dying in a few
weeks. The increased disability during those weeks adds
little to what is learned by calculating YLL. Thus, as the
DALYs were not calculated, any value was not dis-
counted or weighted for YLL as referenced in other
methods [11].
In a recent study [18], it was found that men had about
45% more YLL to COVID-19 than women. This is close
to our findings, where we state that men had around 60%
of YLL to COVID-19 in the selected European countries.
A higher average age-at-death for women and a higher
number of affected men with COVID-19 are factors that
may account for these results [18].
In the United State, it was estimated that, by early July,
there were already 1.2 million YLL to COVID-19 and
that by October that number already exceeded 2.5 mil-
lion [31], 76.16 YLL/10000 inhabitants. This rate is
much higher than that observed in this study, where the
highest rate was registered in the United Kingdom
(62.00 YLL/10000 inhabitants).
The assumption that the mortality by age and cause
registered between 2012 and 2016 would apply to 2020
if COVID-19 had not occurred is fair. CA, CVDs, and
DRSs are chronic and degenerative issues that do not
change over short periods of time, except in cases of
major events that drastically change the environmental,
social, and economic determinants of health, as hap-
pened at the time of the breakup of the Soviet Union
[32]. However, it is certainly an area to be investigated
in the future.
Due to its contagiousness and seriousness, COVID-19
exerts strong pressure on the human and technical re-
sources of the entire health system [33]. A relevant part
of the pre-hospital care facilities, consultations, diagnos-
tic facilities, general inpatient beds, and intensive care
beds are occupied or reserved for patients with COVID-
19 [9]. As it is impossible to increase the supply of these
resources in proportion to the growth in demand, pa-
tients with other pathologies, such as CA, CVDs, DRSs,
end up having their consultations, exams, hospitaliza-
tions, and scheduled surgeries postponed, sometimes
sine die. It is reasonable to assume that the delay or lack
of care may have had an impact on the health and sur-
vival of these patients.
The capacity of each country’s healthcare system to
manage COVID-19 and non-COVID-19 patients may
partly explain the difference in excess YLL to COVID-19
and other causes. Also, a lower intensity flu season in
the analysed countries may be in part responsible for the
lower mortality found in some nations [34]. In Portugal,
as a result of the COVID-19 pandemic, there was a rad-
ical change in the availability and use of health services
[9], because a significant part of the capacity of the na-
tional healthcare system was reallocated for the treat-
ment of patients with COVID-19. In a previous report
[10], we estimated an overall excess of 11,736 deaths be-
tween March and December 2020 in Portugal. This
number is above the estimated excess YLL (10115) be-
cause, although they are related, they represent different
outcomes. YLL only accounts for deaths below the age
of 80 and increases with deaths that occur at younger
ages. In this case, this is in line with the fact that most
excess deaths were mainly seen at advanced ages.
Of all countries, Portugal stands out as having the
highest ratio of excess YLL to non-COVID-19/COVID-
19 YLL. This ratio can be a proxy for the countries cap-
acity in coping with increased pressure on the healthcare
system regarding management of non-COVID-19 dis-
ease. Some characteristics, such as the age distribution
of the population, lack adherence to the policy measures
during different phases of the pandemic, and lack of pre-
paredness on behalf of healthcare systems may have con-
tributed to these results in Portugal.
The increase of incidence of COVID-19 may end up
with YLL beyond the expected values, even beyond the
direct burden of this disease, which parallel to control
the pandemic. Although no correlation was found in our
study (probably due to organizational differences be-
tween healthcare systems between countries), countries
need to be aware that exc-YLL-non-Cvd can seriously
increase if there are no efforts to care for the short- and
long-term management of other diseases. This is prob-
ably related to the lack of clinical follow-up, screenings,
postponing surgeries, diagnostics, and healthcare-
seeking hesitancy.
These results of this paper compare well with other
studies, because they used the conventional methods of
calculating YLL. This study focused on only eight Euro-
pean countries, because it was difficult to get the num-
ber of COVID-19 deaths by age and gender for many
other countries. Our estimates of YLL may have some
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degree of error because mortality data by age and cause
is available only up to 2016 in many countries and is re-
ferred to as provisory for some countries in 2020. Also,
estimates of YLL are conservative, because we used 80
years of age as the upper limit for the range class [21].
These results may be even more conservative due to an
expected decrease in the proportion of deaths by other
non-natural causes, such as traffic accidents, increasing
the proportion of deaths by other natural diseases. In
fact, in a brief analysis, we found that the proportions of
deaths by non-natural causes in Portugal were about 1.7,
1.6, and 1.5% in the years 2017, 2018, and 2019, respect-
ively, and 1.3% in 2020 [35].
Results of this study must be interpreted cautiously. At
first glance, it may seem obvious that countries with a
higher LE are more penalized in the calculations of YLL.
However, some of the characteristics that cause coun-
tries to obtain a higher average LE are also factors that
contribute to better control of deaths at younger ages,
such as a possible better organization and responsiveness
of the National Health Systems, socioeconomic factors,
and/or better health literacy levels, which can assist in
the adoption of more preventive and responsible behav-
iours by their populations in controlling the dissemin-
ation of the virus [36, 37]. YLL is a different measure
and may be very different when comparing it to overall
mortality. It is dependent on the LE for each country
and only for people below that value.
Other limitations are that the calculations of YLL were
not adjusted by age, as some countries did not have
these distributions available. As the data obtained are
grouped, some analyses were not possible to be carried
out, such as the calculation of confidence intervals. Also,
some under-ascertainment in certification of COVID-19
deaths across Europe is not ruled out [38].
This study needs to be replicated later, as since Janu-
ary 2021, the number of cases and deaths of COVID-19
have greatly increased all across Europe [39].
COVID-19 has had a major impact on mortality
rates in Portugal, as in other European countries,
both in terms of the number of deaths and number
of YLL. The relative impact of COVID-19 on the
number of deaths has been greater than that on the
number of YLL, because COVID-19 affects older
people disproportionately. COVID-19 accounts for the
overwhelming number of excess deaths and excess
YLL in Portugal, more so than in other the European
countries considered in this study. All the countries
considered experienced overall excess YLL during the
first year of the pandemic. Spain, Portugal, and the
Netherlands experienced significant excess YLL to
non-COVID-19 causes. COVID-19 accounted for far
more YLL than the excess YLL caused by CA, CVDs,
and DRSs combined.
Conclusions
The relative impact of COVID-19 on the number of
deaths has been greater than that on the number of
YLL, because COVID-19 affects older people dispropor-
tionately. Estimating the number of YLL to COVID-19
is an important method to measure the burden of this
disease per country. Not all countries that had more
YLL to COVID-19 had a greater excess YLL to other
causes. Differences between countries in the number of
excess YLL to non-COVID-19 causes are related to the
capacity of healthcare systems to adapt and respond to
COVID-19 and non-COVID-19 diseases.
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